Our previous study demonstrated that RIPK2 was overexpressed in colorectal cancer (CRC), and, in combination with Fusobacterium nucleatum, was involved in the regulation of CRC metastases (Chen et al., 2020). This evidence concerns the gene RIPK2 and colorectal cancer.